Xeris Biopharma Holdings, Inc. (XERS)
$10.46-0.19%Close
BUYBULL · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.8B
- Beta
- 0.84
- P/E (TTM)
- -105.05
- Short % float
- 4.37%
- Days to cover
- 1.7
- SI change
- -10.6%
- 1W
- +3.26%
- 1M
- +40.40%
- vs SPY 1W
- +2.84%
- vs SPY 1M
- +38.34%
Industry peers
FMP comparable companies · ranked by market cap
- ASNDSELLAscendis Pharma A/S$13.8BRECOVERYQ 35$222.69-0.97%
- CORTBUYCorcept Therapeutics Incorporated$12.8BBULLQ 22$118.54+0.00%
- MBXSELLMBX Biosciences, Inc. Common Stock$2.5BCRISISQ 38$53.25-2.29%
- SEPNSELLSepterna Inc$1.7BRECOVERYQ 27$36.90-2.11%
- ETONSELLEton Pharmaceuticals, Inc.$1.5BRECOVERYQ 33$54.75+0.07%
- GHRSSELLGH Research PLC$1.4BCRISISQ 15$20.45-5.16%
- MNKDSELLMannKind Corporation$1.1BCRISISQ 4$3.42-4.86%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 48
- VALUE
- 8
- GROWTH
- 51
- GARP
- 61
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-255.8%
REV YoY-
ROE-426.3%
EPS YoY-
ROA-4.2%
GROSS83
OP11
NET-5
[VALUATION]
P/E TTM-105.05
P/E FWD33.53
SECTOR PE20.34
INDUSTRY PE13.84
P/B-181.10
P/FCF-
EV/EBITDA116.26
EV/EBIT-
PEG0.69
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.45
ND/EBITDA-
BETA0.84
Company news
FAQ
- What is LOPJLB’s current signal on XERS?
- LOPJLB’s latest quantitative signal on Xeris Biopharma Holdings, Inc. (XERS) is BUY in a BULL regime. Signals are updated daily.
- What market regime is XERS in?
- Xeris Biopharma Holdings, Inc. (XERS) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Xeris Biopharma Holdings, Inc. (XERS) do?
- Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic, hypok…